Veracyte, Inc.
Price Action
Technical Summary
EMERGING TRENDVeracyte, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings growth of 298% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $53.86 | +4.27% | ABOVE |
| 50 SMA | $46.11 | +21.81% | ABOVE |
| 100 SMA | $39.91 | +40.70% | ABOVE |
| 150 SMA | $40.65 | +38.15% | ABOVE |
| 200 SMA | $39.86 | +40.91% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is VCYT in an uptrend right now?
VCYT has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is VCYT overbought or oversold?
VCYT's RSI (14) is 66. The stock is in neutral territory, neither overbought nor oversold.
Is VCYT outperforming the market?
VCYT has a Relative Strength (RS) Rating of 93 out of 99. Yes, VCYT is a market leader, outperforming 93% of all stocks over the past 12 months.
Where is VCYT in its 52-week range?
VCYT is trading at $56.16, which is 92% of its 52-week high ($60.91) and 88% above its 52-week low ($22.61).
How volatile is VCYT?
VCYT has a Beta of 1.55 and 52-week volatility of 61%. It's more volatile than the S&P 500 - expect bigger swings.